COVID-19 Impact on Global Androgenic Alopecia Therapeutics Market Size, Status and Forecast 2020-2026
- BMR3871640
- 91 Pages
- June 2020
- Healthcare
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Androgenic Alopecia Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Androgenic Alopecia Therapeutics industry.
Based on our recent survey, we have several different scenarios about the Androgenic Alopecia Therapeutics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Androgenic Alopecia Therapeutics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Androgenic Alopecia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Androgenic Alopecia Therapeutics market in terms of revenue.
Players, stakeholders, and other participants in the global Androgenic Alopecia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Androgenic Alopecia Therapeutics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Androgenic Alopecia Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Androgenic Alopecia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Androgenic Alopecia Therapeutics market.
The following players are covered in this report:
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy's Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics
Androgenic Alopecia Therapeutics Breakdown Data by Type
Medicine
Surgery
Other
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Androgenic Alopecia Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medicine
1.4.3 Surgery
1.4.4 Other
1.5 Market by Application
1.5.1 Global Androgenic Alopecia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Androgenic Alopecia Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Androgenic Alopecia Therapeutics Industry
1.6.1.1 Androgenic Alopecia Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Androgenic Alopecia Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Androgenic Alopecia Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Androgenic Alopecia Therapeutics Market Perspective (2015-2026)
2.2 Androgenic Alopecia Therapeutics Growth Trends by Regions
2.2.1 Androgenic Alopecia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Androgenic Alopecia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Androgenic Alopecia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Androgenic Alopecia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Androgenic Alopecia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Androgenic Alopecia Therapeutics Players by Market Size
3.1.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Androgenic Alopecia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Androgenic Alopecia Therapeutics Market Concentration Ratio
3.2.1 Global Androgenic Alopecia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Androgenic Alopecia Therapeutics Revenue in 2019
3.3 Androgenic Alopecia Therapeutics Key Players Head office and Area Served
3.4 Key Players Androgenic Alopecia Therapeutics Product Solution and Service
3.5 Date of Enter into Androgenic Alopecia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Androgenic Alopecia Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
5.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Androgenic Alopecia Therapeutics Market Size (2015-2020)
6.2 Androgenic Alopecia Therapeutics Key Players in North America (2019-2020)
6.3 North America Androgenic Alopecia Therapeutics Market Size by Type (2015-2020)
6.4 North America Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Androgenic Alopecia Therapeutics Market Size (2015-2020)
7.2 Androgenic Alopecia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Androgenic Alopecia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Androgenic Alopecia Therapeutics Market Size (2015-2020)
8.2 Androgenic Alopecia Therapeutics Key Players in China (2019-2020)
8.3 China Androgenic Alopecia Therapeutics Market Size by Type (2015-2020)
8.4 China Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Androgenic Alopecia Therapeutics Market Size (2015-2020)
9.2 Androgenic Alopecia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Androgenic Alopecia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Androgenic Alopecia Therapeutics Market Size (2015-2020)
10.2 Androgenic Alopecia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Androgenic Alopecia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Androgenic Alopecia Therapeutics Market Size (2015-2020)
11.2 Androgenic Alopecia Therapeutics Key Players in India (2019-2020)
11.3 India Androgenic Alopecia Therapeutics Market Size by Type (2015-2020)
11.4 India Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Androgenic Alopecia Therapeutics Market Size (2015-2020)
12.2 Androgenic Alopecia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Androgenic Alopecia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Androgenic Alopecia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview and Its Total Revenue
13.1.3 Johnson & Johnson Androgenic Alopecia Therapeutics Introduction
13.1.4 Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview and Its Total Revenue
13.2.3 Merck Androgenic Alopecia Therapeutics Introduction
13.2.4 Merck Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.2.5 Merck Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.3.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Introduction
13.3.4 GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Details
13.4.2 Astellas Pharma Business Overview and Its Total Revenue
13.4.3 Astellas Pharma Androgenic Alopecia Therapeutics Introduction
13.4.4 Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.4.5 Astellas Pharma Recent Development
13.5 Cipla
13.5.1 Cipla Company Details
13.5.2 Cipla Business Overview and Its Total Revenue
13.5.3 Cipla Androgenic Alopecia Therapeutics Introduction
13.5.4 Cipla Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.5.5 Cipla Recent Development
13.6 Almirall
13.6.1 Almirall Company Details
13.6.2 Almirall Business Overview and Its Total Revenue
13.6.3 Almirall Androgenic Alopecia Therapeutics Introduction
13.6.4 Almirall Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.6.5 Almirall Recent Development
13.7 Sun Pharma
13.7.1 Sun Pharma Company Details
13.7.2 Sun Pharma Business Overview and Its Total Revenue
13.7.3 Sun Pharma Androgenic Alopecia Therapeutics Introduction
13.7.4 Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.7.5 Sun Pharma Recent Development
13.8 Reddy's Laboratories
13.8.1 Reddy's Laboratories Company Details
13.8.2 Reddy's Laboratories Business Overview and Its Total Revenue
13.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Introduction
13.8.4 Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.8.5 Reddy's Laboratories Recent Development
13.9 Concert Pharmaceuticals
13.9.1 Concert Pharmaceuticals Company Details
13.9.2 Concert Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Introduction
13.9.4 Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.9.5 Concert Pharmaceuticals Recent Development
13.10 RiverTown Therapeutics
13.10.1 RiverTown Therapeutics Company Details
13.10.2 RiverTown Therapeutics Business Overview and Its Total Revenue
13.10.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Introduction
13.10.4 RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
13.10.5 RiverTown Therapeutics Recent Development
13.11 Brickell Biotech
10.11.1 Brickell Biotech Company Details
10.11.2 Brickell Biotech Business Overview and Its Total Revenue
10.11.3 Brickell Biotech Androgenic Alopecia Therapeutics Introduction
10.11.4 Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
10.11.5 Brickell Biotech Recent Development
13.12 BiologicsMD
10.12.1 BiologicsMD Company Details
10.12.2 BiologicsMD Business Overview and Its Total Revenue
10.12.3 BiologicsMD Androgenic Alopecia Therapeutics Introduction
10.12.4 BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
10.12.5 BiologicsMD Recent Development
13.13 Aclaris Therapeutics
10.13.1 Aclaris Therapeutics Company Details
10.13.2 Aclaris Therapeutics Business Overview and Its Total Revenue
10.13.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Introduction
10.13.4 Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2015-2020)
10.13.5 Aclaris Therapeutics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Androgenic Alopecia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Androgenic Alopecia Therapeutics Revenue
Table 3. Ranking of Global Top Androgenic Alopecia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medicine
Table 6. Key Players of Surgery
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Androgenic Alopecia Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Androgenic Alopecia Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Androgenic Alopecia Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Androgenic Alopecia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Androgenic Alopecia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Androgenic Alopecia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Androgenic Alopecia Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Androgenic Alopecia Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Androgenic Alopecia Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Androgenic Alopecia Therapeutics Players
Table 24. Global Androgenic Alopecia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Androgenic Alopecia Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgenic Alopecia Therapeutics as of 2019)
Table 27. Global Androgenic Alopecia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Androgenic Alopecia Therapeutics Product Solution and Service
Table 30. Date of Enter into Androgenic Alopecia Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Androgenic Alopecia Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Androgenic Alopecia Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Androgenic Alopecia Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Androgenic Alopecia Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Androgenic Alopecia Therapeutics Market Share (2019-2020)
Table 40. North America Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Androgenic Alopecia Therapeutics Market Share by Type (2015-2020)
Table 42. North America Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Androgenic Alopecia Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Androgenic Alopecia Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Androgenic Alopecia Therapeutics Market Share (2019-2020)
Table 46. Europe Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Androgenic Alopecia Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Androgenic Alopecia Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Androgenic Alopecia Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Androgenic Alopecia Therapeutics Market Share (2019-2020)
Table 52. China Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Androgenic Alopecia Therapeutics Market Share by Type (2015-2020)
Table 54. China Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Androgenic Alopecia Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Androgenic Alopecia Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Androgenic Alopecia Therapeutics Market Share (2019-2020)
Table 58. Japan Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Androgenic Alopecia Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Androgenic Alopecia Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Androgenic Alopecia Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Androgenic Alopecia Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Androgenic Alopecia Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Androgenic Alopecia Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Androgenic Alopecia Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Androgenic Alopecia Therapeutics Market Share (2019-2020)
Table 70. India Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Androgenic Alopecia Therapeutics Market Share by Type (2015-2020)
Table 72. India Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Androgenic Alopecia Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Androgenic Alopecia Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Androgenic Alopecia Therapeutics Market Share (2019-2020)
Table 76. Central & South America Androgenic Alopecia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Androgenic Alopecia Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Androgenic Alopecia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Androgenic Alopecia Therapeutics Market Share by Application (2015-2020)
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Astellas Pharma Company Details
Table 96. Astellas Pharma Business Overview
Table 97. Astellas Pharma Product
Table 98. Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 99. Astellas Pharma Recent Development
Table 100. Cipla Company Details
Table 101. Cipla Business Overview
Table 102. Cipla Product
Table 103. Cipla Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 104. Cipla Recent Development
Table 105. Almirall Company Details
Table 106. Almirall Business Overview
Table 107. Almirall Product
Table 108. Almirall Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 109. Almirall Recent Development
Table 110. Sun Pharma Company Details
Table 111. Sun Pharma Business Overview
Table 112. Sun Pharma Product
Table 113. Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 114. Sun Pharma Recent Development
Table 115. Reddy's Laboratories Business Overview
Table 116. Reddy's Laboratories Product
Table 117. Reddy's Laboratories Company Details
Table 118. Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 119. Reddy's Laboratories Recent Development
Table 120. Concert Pharmaceuticals Company Details
Table 121. Concert Pharmaceuticals Business Overview
Table 122. Concert Pharmaceuticals Product
Table 123. Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 124. Concert Pharmaceuticals Recent Development
Table 125. RiverTown Therapeutics Company Details
Table 126. RiverTown Therapeutics Business Overview
Table 127. RiverTown Therapeutics Product
Table 128. RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 129. RiverTown Therapeutics Recent Development
Table 130. Brickell Biotech Company Details
Table 131. Brickell Biotech Business Overview
Table 132. Brickell Biotech Product
Table 133. Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 134. Brickell Biotech Recent Development
Table 135. BiologicsMD Company Details
Table 136. BiologicsMD Business Overview
Table 137. BiologicsMD Product
Table 138. BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 139. BiologicsMD Recent Development
Table 140. Aclaris Therapeutics Company Details
Table 141. Aclaris Therapeutics Business Overview
Table 142. Aclaris Therapeutics Product
Table 143. Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2015-2020) (Million US$)
Table 144. Aclaris Therapeutics Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgenic Alopecia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Androgenic Alopecia Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Androgenic Alopecia Therapeutics Report Years Considered
Figure 10. Global Androgenic Alopecia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Androgenic Alopecia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Androgenic Alopecia Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Androgenic Alopecia Therapeutics Market Share by Players in 2019
Figure 15. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgenic Alopecia Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Androgenic Alopecia Therapeutics Revenue in 2019
Figure 17. North America Androgenic Alopecia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Androgenic Alopecia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Androgenic Alopecia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Androgenic Alopecia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Androgenic Alopecia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Androgenic Alopecia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Androgenic Alopecia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Johnson & Johnson Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 26. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Merck Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 28. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 30. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Astellas Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 32. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Cipla Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 34. Almirall Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Almirall Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 36. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Sun Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 38. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Reddy's Laboratories Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 40. Concert Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Concert Pharmaceuticals Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 42. RiverTown Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. RiverTown Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 44. Brickell Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Brickell Biotech Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 46. BiologicsMD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. BiologicsMD Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 48. Aclaris Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Aclaris Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
